The Cannigma
APRIL 14, 2021
I probably Spidermanned myself but instead of superpowers I just got super chronic pain,” Dr. Ross said. Fibromyalgia is a debilitating disease that causes widespread chronic pain as well as fatigue and memory problems, among other symptoms. It is about twice as common in women than in men.
The Cannigma
NOVEMBER 21, 2021
For example, one 2009 study found that cannabis with only 2.5% But it is impossible to tell whether cannabis use reduces educational attainment, or if some other characteristic encourages both lowered achievement and cannabis use – such as mental health conditions, chronic pain, or even a troubled family life. 14 15 16.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
NOVEMBER 8, 2019
A 2009 Canadian clinical trial of synthetic cannabinoid medication, nabilone , found: The majority of patients (72%) receiving nabilone experienced either cessation of nightmares or a significant reduction in nightmare intensity. Medical marijuana may also play a role in treating nightmares.
TheAnswerPage
JANUARY 11, 2022
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).
Greencamp
AUGUST 25, 2018
Bruce Banner is rich in THC and works well for pain and fatigue so lupus patients can benefit on multiple levels. A very uplifting strain and great for suppressing nausea, Super Silver Haze can also help lupus patients overcome muscle spasms and chronic pain. Super Silver Haze. Barrie, N., & Manolios, N.
Cannabis Law Report
JUNE 11, 2019
Poirier sued following a surgical procedure that left her with chronic pain and limitations affecting her lifestyle and career. The accident also reactivated a pre-existing psychological condition which manifested as a chronic pain syndrome, and a pre-existing depressive disorder which was in partial remission at the time of trial.
The Cannigma
OCTOBER 8, 2021
The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009. The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients.
Expert insights. Personalized for you.
126 
Let's personalize your content